Gray Zone - Treating Cervical Cancer in a Patient with Pelvic Kidney: Navigating a Narrow Therapeutic Window
The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.
Category
- Gynecologic
Format
- Journal Activities
Credits
- 1.00 AMA PRA Category 1 Credit™
Cost $0.00
Disparities in Gynecologic Cancer Care and Outcomes in the Age of Molecular Profiling and Targeted Therapies: Etiologies and Solutions
In contradistinction to many other malignancies, gynecologic cancers continue to rise in incidence and/or mortality. By 2030, endometrial cancer will be one of the top three female cancers, exceeding colon cancer rates.
Category
- Gynecologic
Format
- Sessions onDemand
Credits
- 1.25 AMA PRA Category 1 Credit™
- 1.25 Certificate of Attendance
Cost $49.00
A Systematic Review of Patient-Reported Outcomes on the Impact of Radiotherapy on Sexual Health in Gynecologic Cancer Patients
This education activity reviews the evidence on the impact of radiotherapy on sexual health in patients with gynecological malignancies, using a systematic review methodology. This activity describes sexual dysfunction prevalence and severity, trajectories, and contributing factors.
Category
- Gynecologic
Format
- Journal Activities
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $49.00
Executive Summary of the American Radium Society™ (ARS) Appropriate Use Criteria (AUC) for Management of Locally Advanced Endometrial Cancer
This journal activity provides practitioners with the knowledge needed to identify major prognostic factors and the role of RT in locally advanced endometrial cancer, emphasizing multimodality therapy and molecular risk stratification in and highlighting the growing role of immunotherapy and prec
Category
- Gynecologic
Format
- Journal Activities
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Certificate of Attendance
Cost $49.00

Facebook
X
LinkedIn
Forward